Talvinen K - Search Results

1

Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation.

Ahotupa M, Marniemi J, Lehtimäki T, Talvinen K, Raitakari OT, Vasankari T, Viikari J, Luoma J, Ylä-Herttuala S. Ahotupa M, et al. Among authors: talvinen k. Clin Biochem. 1998 Jun;31(4):257-61. doi: 10.1016/s0009-9120(98)00018-6. Clin Biochem. 1998. PMID: 9646949

2

Cloning of a novel phospholipase A2 from the cnidarian Adamsia carciniopados.

Talvinen KA, Nevalainen TJ. Talvinen KA, et al. Comp Biochem Physiol B Biochem Mol Biol. 2002 Jul;132(3):571-8. doi: 10.1016/s1096-4959(02)00073-8. Comp Biochem Physiol B Biochem Mol Biol. 2002. PMID: 12091102

3

Expression of group II phospholipase A2 in the liver in acute pancreatitis.

Talvinen KA, Kemppainen EA, Nevalainen TJ. Talvinen KA, et al. Scand J Gastroenterol. 2001 Nov;36(11):1217-21. doi: 10.1080/00365520152584879. Scand J Gastroenterol. 2001. PMID: 11686224

4

mRNA differential display of gene expression in colonic carcinoma.

Ojala P, Sundström J, Grönroos JM, Virtanen E, Talvinen K, Nevalainen TJ. Ojala P, et al. Among authors: talvinen k. Electrophoresis. 2002 Jun;23(11):1667-76. doi: 10.1002/1522-2683(200206)23:11<1667::AID-ELPS1667>3.0.CO;2-0. Electrophoresis. 2002. PMID: 12179986

5

Biochemical and clinical approaches in evaluating the prognosis of colon cancer.

Talvinen K, Tuikkala J, Grönroos J, Huhtinen H, Kronqvist P, Aittokallio T, Nevalainen O, Hiekkanen H, Nevalainen T, Sundström J. Talvinen K, et al. Anticancer Res. 2006 Nov-Dec;26(6C):4745-51. Anticancer Res. 2006. PMID: 17214335 Free article.

6

Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators.

Surrel F, Jemel I, Boilard E, Bollinger JG, Payré C, Mounier CM, Talvinen KA, Laine VJ, Nevalainen TJ, Gelb MH, Lambeau G. Surrel F, et al. Mol Pharmacol. 2009 Oct;76(4):778-90. doi: 10.1124/mol.108.053371. Epub 2009 Jul 14. Mol Pharmacol. 2009. PMID: 19602573 Free PMC article.

7

Altered expression of p120catenin predicts poor outcome in invasive breast cancer.

Talvinen K, Tuikkala J, Nykänen M, Nieminen A, Anttinen J, Nevalainen OS, Hurme S, Kuopio T, Kronqvist P. Talvinen K, et al. J Cancer Res Clin Oncol. 2010 Sep;136(9):1377-87. doi: 10.1007/s00432-010-0789-8. Epub 2010 Feb 12. J Cancer Res Clin Oncol. 2010. PMID: 20151151

8

Genomic changes of the 55 kDa subunit of DNA polymerase epsilon in human breast cancer.

Zhou Q, Effati R, Talvinen K, Pospiech H, Syväoja JE, Collan Y. Zhou Q, et al. Among authors: talvinen k. Cancer Genomics Proteomics. 2008 Sep-Oct;5(5):287-92. Cancer Genomics Proteomics. 2008. PMID: 19129559 Free article.

9

Mutations/polymorphisms in the 55 kDa subunit of DNA polymerase epsilon in human colorectal cancer.

Zhou Q, Talvinen K, Sundström J, Elzagheid A, Pospiech H, Syväoja JE, Collan Y. Zhou Q, et al. Among authors: talvinen k. Cancer Genomics Proteomics. 2009 Nov-Dec;6(6):297-304. Cancer Genomics Proteomics. 2009. PMID: 20065316 Free article.

10

Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients.

Gurvits N, Autere TA, Repo H, Nykänen M, Kuopio T, Kronqvist P, Talvinen K. Gurvits N, et al. Among authors: talvinen k. J Cancer Res Clin Oncol. 2018 Apr;144(4):657-666. doi: 10.1007/s00432-018-2586-8. Epub 2018 Jan 23. J Cancer Res Clin Oncol. 2018. PMID: 29362919 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters